One of the persistent frustrations with GLP-1 weight loss drugs is the commitment they require. Weekly injections, strict maintenance dosing,...
Novo
Novo Nordisk President and CEO Mike Doustdar discusses the company's collaboration with artificial intelligence to accelerate drug discovery and development....
In 2023, Danish drugmaker Novo Nordisk briefly surpassed the luxury conglomerate LVMH to become Europe’s most valuable company by market...
I believe that when a stock is down nearly 10% year to date and down 38% over three years, the...
Investors who had hopes that Novo Nordisk (NVO) could succeed outside of weight-loss drugs were disappointed on Friday, July 31.The...
Check out what's clicking on FoxBusiness.com. Novo Nordisk sued Eli Lilly on Tuesday, accusing its rival of misleading consumers by...
Novo Nordisk (NVO) has spent 2026 trying to convince investors that the worst is behind it.After a punishing year, the...
Novo Nordisk A/S Chief Executive Officer Mike Doustdar says the company’s blockbuster obesity drugs could ultimately pull it into increasingly...
Veru (VERU) stock has not been easy to own.The little biotech has spent years persuading investors that its experimental obesity...
Novo Nordisk has long been a core holding for quality-focused institutional investors, having dominated the global insulin market for more...
The race to develop the next generation of medicines just got faster. At least, that is the bet Novo Nordisk...
Hims & Hers (HIMS) has taken a beating, with the stock down roughly 70% from its $70 peak and now...